Boston Scientific Corporation
BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardiovā¦ read more
Healthcare
Medical Devices
33 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$53.06
Price-1.92%
-$1.04
1Y
Price
Market Cap
$78.866b
Large
Price/Earnings 3y Avg5y Avg
22.2x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+20.6%
EBITDA Margin+25.7%
Net Profit Margin+3.3%
Free Cash Flow Margin+20.6%
EBITDA Margin+25.7%
Net Profit Margin+3.3%
Free Cash Flow MarginRevenue
$20.615b
+2.7%
1y CAGR+13.4%
3y CAGR+13.1%
5y CAGREarnings
$3.553b
+23.1%
1y CAGR+31.7%
3y CAGR+55.8%
5y CAGREPS
$2.38
+22.7%
1y CAGR+31.6%
3y CAGR+58.1%
5y CAGRBook Value
$26.104b
$44.351b
Assets$18.247b
Liabilities$11.029b
DebtDebt to Assets
24.9%
2.3x
Debt to EBITDAFree Cash Flow
$3.442b
-5.9%
1y CAGR+29.2%
3y CAGR+43.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company